Attain Performa(TM) Quadripolar Lead Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1202 participants.

Also called NCT01751022

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,202 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01751022
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Austria, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Greece, Hungary, India, Israel, Italy, Malaysia, Netherlands, Norway, Romania, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01751022. Allocation not applicable; no masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2015-02 (actual). Results posted on 2016-12-05.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Attain Performa(TM) Quadripolar Lead Study
Condition
Heart Failure
Intervention (Device)
Device: Attain Performa Pacing Lead (along with a standard CRT-D system)
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure (class: industry)

Record details

Record id
cardio:ct-nct01751022
Content hash
9839839d5d59903d42c12627a0a996ab0dab179c758147f92b22280253ea4ada